Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bertusi

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1977
[Association of breast cancer and chronic myelogenous leukemia]P Malacarne, M Bertusi, L Bariani
Diabetes|February 1, 1977
Tolbutamide-induced hemolytic anemiaP Malacarne, G Castaldi, M Bertusi, et al.
The American Journal of Emergency Medicine|May 1, 1996
Spontaneous rupture of the spleenM Gallerani, A Vanini, R Salmi, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1980
[Clinical study of multiple primary neoplasms]M Bertusi, V Abbasciano, A Gallerani, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|April 30, 1987
RFLPs of the Ha-ras1 protooncogene in subjects with colon-rectal carcinomasI Maestri, A Castagnoli, M Bertusi, et al.
Tumori|July 1, 1995
Cisplatin and VP16 in metastatic breast carcinoma as a third-line chemotherapy: a randomized study comparing low versus high doses of cisplatinG Ceci, G Bisagni, G Cocconi, et al.
Minerva Medica|March 31, 1984
[Therapy and follow-up of breast cancer. Experiences in 11 years of observation]D De Anna, M Bertusi, M Marchi, et al.
Tumori|June 30, 1989
Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC)R Passalacqua, G Bisagni, M Bertusi, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1977
[Association of breast cancer and chronic myelogenous leukemia]P Malacarne, M Bertusi, L Bariani
Diabetes|February 1, 1977
Tolbutamide-induced hemolytic anemiaP Malacarne, G Castaldi, M Bertusi, et al.
The American Journal of Emergency Medicine|May 1, 1996
Spontaneous rupture of the spleenM Gallerani, A Vanini, R Salmi, et al.
Rivista Di Emoterapia Ed Immunoematologia|January 1, 1980
[Clinical study of multiple primary neoplasms]M Bertusi, V Abbasciano, A Gallerani, et al.
Bollettino Della Societa Italiana Di Biologia Sperimentale|April 30, 1987
RFLPs of the Ha-ras1 protooncogene in subjects with colon-rectal carcinomasI Maestri, A Castagnoli, M Bertusi, et al.
Tumori|July 1, 1995
Cisplatin and VP16 in metastatic breast carcinoma as a third-line chemotherapy: a randomized study comparing low versus high doses of cisplatinG Ceci, G Bisagni, G Cocconi, et al.
Minerva Medica|March 31, 1984
[Therapy and follow-up of breast cancer. Experiences in 11 years of observation]D De Anna, M Bertusi, M Marchi, et al.
Tumori|June 30, 1989
Lonidamine in advanced colorectal cancer: a phase II study of the Italian Oncology Group for Clinical Research (GOIRC)R Passalacqua, G Bisagni, M Bertusi, et al.
Pageof 1